secwatch.observer — SEC 8-K summary
======================================

Issuer:     Karyopharm Therapeutics Inc. (KPTI)
CIK:        0001503802
Form:       8-K
Filed at:   2026-03-03T23:59:59+00:00
Accession:  0001503802-26-000006
Event type: debt
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Karyopharm defers debt payments, requires $25M equity raise to extend runway past mid-2026
--------------------------------------------------------------------------------

- Second Amendment to Credit Agreement defers June 2026 principal payment to September 10, 2026; interest due June 30 paid in kind.
- Minimum liquidity covenant reduced to $10M through Oct 10, 2026 (from $25M) conditional on $25M+ equity raise before June 10, 2026.
- Forbearance agreements with lenders and noteholders defer payment-related defaults through Sep 30, 2026, and liquidity covenant breaches through Oct 10, 2026.
- Phase 3 XPORT-EC 042 top-line data still expected mid-2026; the amendments aim to extend cash runway beyond that readout.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503802/000150380226000006/0001503802-26-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503802/000150380226000006/kpti-20260227.htm
  HTML page:      https://secwatch.observer/filing/0001503802-26-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer